Poisoning deaths from “novel” benzodiazepines (NBZDs)—designed to mimic brand-name drugs like Valium and Xanax but with greater potency—have spiked in the last six years. Out of nearly 260 fatal NBZD-related toxicity cases reported since 2013, about 87% of these deaths occurred between 2020 and 2025, according to findings from the National Drug and Alcohol Research Center, UNSW Sydney.
This article was originally published on MedicalXpress.com

